Diabetes Clinical Trials

Showing 5621-5640 of 7,874 trials

Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers

NCT01515592

This trial is conducted in Japan. The aim of this trial is to assess the safety and tolerability of 20 µg/kg and 25 µg/kg liraglutide in healthy Japanese male subjects.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S24 participantsStarted Jan 2006

Tokyo, Japan

COMPLETEDPhase 1

Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes

NCT01507311

This trial is conducted in Europe. The aim of this trial is to assess the effect of NNC 90-1170 (liraglutide) on pulsatile insulin secretion and insulin secretion after a standard meal in subjects with type 2 diabetes.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S11 participantsStarted Sep 1999

Århus C, Denmark

COMPLETEDPhase 2

Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes

NCT01508923

This trial is conducted in Europe. The aim of this trial is to determine the effect of NNC 90-1170 (liraglutide) on glucose and hormonal profiles, fasting gluconeogenesis and insulin secretion in subjects with type 2 diabetes.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S17 participantsStarted May 2001

Århus C, Denmark

Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers

Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes

Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes

Related Searches

A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control

Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Metabolic Effects of Stevia in Type 2 Diabetic Patients

Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes

A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes

The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy

A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy Subjects

A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes

A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes

Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

Study of the Potential of a Macronutrient Balanced Normocaloric Diet to Treat Lifestyle Diseases

A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes